Latest Insider Transactions at Tarsus Pharmaceuticals, Inc. (TARS)
This section provides a real-time view of insider transactions for Tarsus Pharmaceuticals, Inc. (TARS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Tarsus Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Tarsus Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 23
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
737
-7.9%
|
$8,844
$12.15 P/Share
|
|
Mar 23
2023
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
371
-2.21%
|
$4,452
$12.15 P/Share
|
|
Mar 23
2023
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
372
-0.7%
|
$4,464
$12.15 P/Share
|
|
Mar 23
2023
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
345
-2.98%
|
$4,140
$12.15 P/Share
|
|
Mar 22
2023
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
332
-1.02%
|
$3,984
$12.64 P/Share
|
|
Mar 22
2023
|
Jose M. Trevejo CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
529
-7.45%
|
$6,348
$12.64 P/Share
|
|
Mar 22
2023
|
Seshadri Neervannan Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
379
-0.68%
|
$4,548
$12.64 P/Share
|
|
Mar 22
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
709
-7.06%
|
$8,508
$12.64 P/Share
|
|
Mar 22
2023
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
357
-2.08%
|
$4,284
$12.64 P/Share
|
|
Mar 22
2023
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
357
-0.67%
|
$4,284
$12.64 P/Share
|
|
Mar 22
2023
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
333
-2.8%
|
$3,996
$12.64 P/Share
|
|
Mar 21
2023
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
326
-0.99%
|
$3,912
$12.89 P/Share
|
|
Mar 21
2023
|
Jose M. Trevejo CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
519
-6.81%
|
$6,228
$12.89 P/Share
|
|
Mar 21
2023
|
Seshadri Neervannan Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
372
-0.67%
|
$4,464
$12.89 P/Share
|
|
Mar 21
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
679
-6.33%
|
$8,148
$12.89 P/Share
|
|
Mar 21
2023
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
350
-2.0%
|
$4,200
$12.89 P/Share
|
|
Mar 21
2023
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
349
-0.65%
|
$4,188
$12.89 P/Share
|
|
Mar 21
2023
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
326
-2.67%
|
$3,912
$12.89 P/Share
|
|
Mar 20
2023
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
357
-2.0%
|
$4,284
$12.61 P/Share
|
|
Mar 20
2023
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
333
-2.65%
|
$3,996
$12.61 P/Share
|
|
Mar 20
2023
|
Jose M. Trevejo CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
530
-6.5%
|
$6,360
$12.61 P/Share
|
|
Mar 20
2023
|
Seshadri Neervannan Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
380
-0.68%
|
$4,560
$12.61 P/Share
|
|
Mar 20
2023
|
Mark J. Holdbrook V.P., Clinical Affairs |
SELL
Open market or private sale
|
Direct |
198
-5.84%
|
$2,376
$12.61 P/Share
|
|
Mar 20
2023
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
358
-0.66%
|
$4,296
$12.61 P/Share
|
|
Mar 20
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
741
-6.46%
|
$8,892
$12.61 P/Share
|
|
Mar 20
2023
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
333
-1.01%
|
$3,996
$12.61 P/Share
|
|
Mar 17
2023
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
339
-1.87%
|
$4,407
$13.28 P/Share
|
|
Mar 17
2023
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
316
-2.45%
|
$4,108
$13.28 P/Share
|
|
Mar 17
2023
|
Jose M. Trevejo CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
504
-5.82%
|
$6,552
$13.28 P/Share
|
|
Mar 17
2023
|
Seshadri Neervannan Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
360
-0.64%
|
$4,680
$13.28 P/Share
|
|
Mar 17
2023
|
Mark J. Holdbrook V.P., Clinical Affairs |
SELL
Open market or private sale
|
Direct |
188
-5.26%
|
$2,444
$13.28 P/Share
|
|
Mar 17
2023
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
339
-0.62%
|
$4,407
$13.28 P/Share
|
|
Mar 17
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
795
-6.49%
|
$10,335
$13.28 P/Share
|
|
Mar 17
2023
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
316
-0.95%
|
$4,108
$13.28 P/Share
|
|
Mar 16
2023
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
313
-2.37%
|
$4,069
$13.43 P/Share
|
|
Mar 16
2023
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
337
-1.82%
|
$4,381
$13.43 P/Share
|
|
Mar 16
2023
|
Mark J. Holdbrook V.P., Clinical Affairs |
SELL
Open market or private sale
|
Direct |
187
-4.97%
|
$2,431
$13.43 P/Share
|
|
Mar 16
2023
|
Seshadri Neervannan Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
357
-0.63%
|
$4,641
$13.43 P/Share
|
|
Mar 16
2023
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
336
-0.61%
|
$4,368
$13.43 P/Share
|
|
Mar 16
2023
|
Jose M. Trevejo CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
499
-5.45%
|
$6,487
$13.43 P/Share
|
|
Mar 16
2023
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,313
-6.91%
|
$69,069
$13.44 P/Share
|
|
Mar 16
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
791
-6.06%
|
$10,283
$13.43 P/Share
|
|
Mar 15
2023
|
William J Phd Link Director |
BUY
Other acquisition or disposition
|
Indirect |
52,194
+43.18%
|
-
|
|
Mar 15
2023
|
William J Phd Link Director |
SELL
Other acquisition or disposition
|
Indirect |
215,575
-50.0%
|
-
|
|
Mar 15
2023
|
Dianne C. Whitfield Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,462
+25.28%
|
-
|
|
Mar 15
2023
|
Bryan Wahl General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,790
+20.56%
|
-
|
|
Mar 15
2023
|
Mark J. Holdbrook V.P., Clinical Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
2,653
+41.34%
|
-
|
|
Mar 15
2023
|
Seshadri Neervannan Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,097
+8.22%
|
-
|
|
Mar 15
2023
|
Aziz Mottiwala Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,790
+8.02%
|
-
|
|
Mar 15
2023
|
Jose M. Trevejo CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,549
+45.2%
|
-
|